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N-Heterocyclic carbene (NHC)-catalysed redox [4+2]-hetero-Diels-Alder reactions of α-
aroyloxyaldehydes with either β,γ-unsaturated α-ketoesters or α,β-unsaturated γ-ketoesters 
generates substituted syn-dihydropyranones in good yield with excellent enantioselectivity (up 
to >99:1 er). The product diastereoselectivity is markedly dependent upon the nature of the 
unsaturated enone substituent. The presence of either electron-neutral or electron-rich aryl 
substituents gives excellent diastereoselectivity (up to >99:5 dr), while electron-deficient aryl 
substituents give reduced diastereoselectivity. In these cases, the syn-dihydropyranone 
products are more susceptible to base-promoted epimerisation at the C(4)-position under the 
reaction conditions, accounting for the lower diastereoselectivity obtained.  
  
1 Introduction 
N-Heterocyclic carbenes (NHCs) are versatile organocatalysts that exhibit a wide range of 
reactivity.1 Of the multiple activation modes accessible through NHC catalysis, the generation 
and use of azolium enolates has emerged as a powerful strategy for the enantioselective 
synthesis of complex small-molecules. A number of methods has been developed for the 
formation of azolium enolate intermediates (Scheme 1a). For example, addition of an NHC 
into a substituted ketene directly generates an azolium enolate,2 while deprotonation of acyl 
azolium intermediates, themselves generated from either the reaction of NHCs with aldehydes 
under oxidative conditions3 or the addition of NHCs into activated carboxylic esters,4 also leads 
to enolate formation. Another common strategy for azolium enolate formation is the addition 
of NHCs into aldehydes bearing α-reducible functional groups, which subsequently undergo a 
redox process to form the desired enolate.5-10 Examples of such α-reducible aldehydes include 
α-chloroaldehydes,6 enals,7 α-aryloxyaldehydes,8 and formyl cyclopropanes9 (Scheme 1b). We 
have previously reported that bench-stable α-aroyloxyaldehydes 1 are also efficient redox 
azolium enolate precursors.10  
 
 
Scheme 1. Generation of azolium enolate intermediates. 
 
Azolium enolates generated from NHCs and α-reducible aldehydes react with a variety of 
electrophiles to generate a diverse array of products. Of particular relevance is the reaction of 
azolium enolates with substituted enones in enantioselective [4+2]-hetero-Diels-Alder 
processes to form stereodefined dihydropyranone products. For example, Bode and co-workers 
demonstrated that azolium enolates generated from α-chloroaldehydes react with both β,γ-
unsaturated α-ketoesters and α,β-unsaturated γ-ketoesters to form syn-dihydropyranones 3 with 
excellent enantioselectivity (Scheme 2a).6b In this case, the use of unsaturated ketoesters 
bearing either alkyl or electron-neutral/rich aryl substituents generally formed the product 
dihydropyranones in high diastereoselectivity. Notably, the presence of electron-deficient aryl 
(4-BrC6H4) or heteroaryl (2-furyl) substituents lead to a decrease in diastereoselectivity, 
although the origin of the reduced dr was not further investigated. This methodology was 
subsequently extended to the use of the bench-stable sodium bisulfate adducts of α-
chloroaldehydes under biphasic conditions, allowing the use of unsubstituted 
chloroacetaldehyde sodium bisulfite to form dihydropyranones containing a single 
stereocentre.6c The NHC-catalysed redox hetero-Diels-Alder reaction of enals with unsaturated 
ketoesters has also been reported to proceed with high levels of stereoselectivity.7d  
α-Aroyloxyaldehydes have previously been used as azolium enolate precursors in NHC-
catalysed [4+2]-hetero-Diels-Alder reactions with various trifluoromethyl enones (Scheme 
2b)10b,d and α,β-unsaturated trichloromethyl ketones10e to form functionalised  
 
 Scheme 2. NHC-catalysed redox [4+2]-hetero-Diels-Alder reactions. 
syn-dihydropyranones 4 with high diastereo- and enantioselectivity. Azolium enolates 
generated from α-aroyloxyaldehydes also undergo [2+2]10f and [3+2]-cycloadditions,10g as well 
as enantioselective α-aminations to from N-aryl amino acid derivatives.10c 
Herein, the NHC-catalysed redox hetero-Diels-Alder reaction of bench-stable α-
aroyloxyaldehydes with both β,γ-unsaturated α-ketoesters and α,β-unsaturated γ-ketoesters is 
reported to form syn-dihydropyranones (5 and 6) with excellent enantioselectivity (Scheme 
2c). The effect of various aryl substituents on the unsaturated ketoesters on the reaction 
diastereoselectivity is assessed, with control experiments performed to determine the origin of 
the reduced product diastereoselectivity observed in some cases.  
2 Results and discussion 
2.1 Reaction optimisation 
First, the reaction of azolium enolates derived from α-aroyloxyaldehydes11 with β,γ-
unsaturated α-ketoesters was studied. Treating α-aroyloxyaldehyde 7 and α-ketoester 8 with 
NHC precatalyst 2 (20 mol%) and Et3N (1.5 eq) in THF at room temperature gave 
dihydropyranone 9 in a promising 50% yield and 92:8 dr with excellent enantioselectivity 
(>99:1 er) for the major syn-diastereoisomer (Table 1, entry 1).12 Lowering the catalyst loading 
led to increased reaction times and decreased diastereoselectivity, although the 
enantioselectivity for both diastereoisomers was high (Table 1, entries 2 and 3). Decreasing the 
reaction temperature to –78 °C led to an increase in diastereoselectivity (> 99:1 dr), but gave 
lower conversion into the desired product (Table 1, entry 4). Starting the reaction at 0 °C and 
allowing it to warm slowly to room temperature using 10 mol% 2 gave an excellent 
compromise between reactivity and stereoselectivity, with syn-dihydropyranone 9 isolated in 
93% yield with >95:5 dr and >99:1 er (Table 1, entry 5). The relative and absolute configuration 
of the major product was assigned by analogy to that of a known derivative formed during 
investigation of the reaction substrate scope (vide infra). 
2.2 Reaction scope with β,γ-unsaturated α-ketoesters 
The scope of the NHC-catalysed redox reaction of various α-aroyloxyaldehydes with a range 
of β,γ-unsaturated α-ketoesters was studied under the previously optimised conditions (Table 
2). The reaction worked well with different alkyl α-aroyloxyaldehyde substituents, forming 
syn-dihydropyranones 10 and 11 in good yields with excellent levels of stereoselectivity (up to 





Entry NHC (mol%) T (°C) Time (h) Conversion (%)a,b dra erc 
1 2 (20) rt 5 >90 (50) 92:8 >99:1 
2 2 (10) rt 12 >90 85:15 N/D 
3 2 (1) rt 48 >90 76:24 
>99:1 (syn) 
>99:1 (anti) 
4 2 (10) –78 12 45 >95:5 N/D 
5 2 (10) 0 to rt 12 >90 (93) >95:5 >99:1 
a Determined by 1H NMR analysis of the crude reaction mixture. 
b Isolated yield after purification by column chromatography in parentheses. 
c er of major diastereoisomer determined by HPLC analysis. 
 
aromatic substituents (4-MeC6H4 and 4-MeOC6H4) gave dihydropyranones 12-15 in high 
yields, but with slightly reduced levels of syn-diastereoselectivity (≥91:9 dr) compared with 
the reaction with phenyl substituted α-ketoester 8. However, in each case the major syn-
diastereoisomer was formed with high levels of enantioselectivity (≥96:4 er). The relative 
configuration of syn-dihydropyranone 12 could be confirmed through comparison of its 
spectroscopic data with the literature,6b while the absolute configuration was confirmed 
through comparison of its specific rotation [96:4 er, 20
D][  +299.4 (c 0.5, CHCl3)] with the 
reported value [(3S,4S)-12, 98.5:1.5 er, 20
D][  +310.3 (c 1.0, CHCl3)].
6b The incorporation of a 
more electron-deficient aryl bromine substituent led to a modest 42% yield of dihydropyranone 
16 in a reduced 89:11 dr, although the enantioselectivity remained high (99:1 er). An extended 
aromatic 2-naphthyl substituent was also successfully incorporated, forming 17 in 48% yield 
with good stereoselectivity (94:6 dr, >99:1 er).  
  
Table 2 
Scope of the reaction using β,γ-unsaturated α-ketoestersa–c 
 
a Isolated yields of single diastereoisomers (>95:5 dr) after column chromatography. 
b dr determined by 1H NMR analysis of the crude reaction mixtures. 
c er of major diastereoisomer determined by HPLC analysis. 
 
To investigate the reduced diastereoselectivity observed in certain cases, a series of control 
experiments was performed (Table 3). Treating isolated syn-dihydropyranone 9 (>95:5 dr) with 
NHC precatalyst 2 (15 mol%) and Et3N (15 mol%) resulted in epimerisation, returning 9 in 
89:11 dr after 65 h at room temperature (Table 3, entry 1). Furthermore, significant amounts 
of products 18 and 19 arising from double bond isomerisation were also observed, indicating 
that the initial deprotonation leading to both epimerisation and isomerisation is most likely to 
occur at the C(4) position in conjugation with the enone.13,14 The use of Et3N (15 mol%) alone 
resulted in reduced amounts of both epimerisation (93:7 dr after 65 h) and isomerisation, 
suggesting that the free NHC is capable of deprotonating 9 (Table 3, entry 2). Treating 9 with 
a stoichiometric amount of Et3N (1 eq) resulted in increased levels of isomerisation into both 
18 and 19 (Table 3, entry 3), while increased reaction times led to further isomerisation and 
increased epimerisation of the remaining dihydropyranone 9 (Table 3, entry 4). The NHC and 
base-promoted epimerisation and isomerisation of the product syn-dihydropyranones could 
therefore account for the reduced diastereoselectivity and lower yields obtained in certain 
instances (Table 2).  
 
Table 3  
Investigation into the epimerisation of syn-9 
 
Entry 2 (mol%) Et3N (mol%) 9/18/19
a dr 9a dr 18a 
1 15 15 50:30:20 89:11 59:41 
2 – 15 92:8:0 93:7 55:45 
3 – 100 48:37:15 94:6 60:40 
4b – 100 27:14:59 80:20 52:48 
a Determined by 1H NMR analysis of the crude reaction mixtures. 
b Entry 3 re-subjected to the same conditions for a further 120 h. 
 
2.3 Reactions with α,β-unsaturated γ-ketoesters 
Next, the use of α,β-unsaturated γ-ketoesters in the NHC-catalysed redox process with α-
aroyloxyaldehydes was investigated (Table 4). In this case, only 5 mol% NHC precatalyst 2 
was required alongside Et3N (1.5 eq) in THF at room temperature to form the corresponding 
syn-dihydropyranones in high yields and with excellent stereoselectivity. α-Aroyloxyaldehydes 
bearing alkyl and benzyl substituents were well tolerated, forming products 20-22 in high 
yields with excellent diastereo- and enantioselectivity (>95: 5 dr, >99:1 er). The relative and 
absolute configuration of 21 was confirmed through comparison of its spectroscopic data and 
specific rotation [>99:1 er, 20
D][  +173 (c 1.05 in CHCl3)] with the literature [>99:1 er, 
20
D][  
+107 (c 0.82, CHCl3)],
6c with all other products in this series assigned by analogy. The reaction 
using an α,β-unsaturated γ-ketoester bearing a methyl substituent needed to be heated at 40 °C 
  
Table 4 
Scope of the reaction using α,β-unsaturated γ-ketoestersa–c 
 
a Isolated yields of single diastereoisomers (>95:5 dr) after column chromatography. 
b dr determined by 1H NMR analysis of the crude reaction mixtures. 
c er of major diastereoisomer determined by HPLC analysis. 
d 10 mol% 2 used. 
e Reaction performed at 40 °C using Cs2CO3 instead of Et3N. 
 
and required the use of Cs2CO3 as base to form syn-dihydropyranone 23 in 65% yield as a 
single diastereoisomer in high enantioselectivity. The absolute configuration of 23 could also 
be confirmed through comparison of its specific rotation [98.5:1.5 er, 20
D][  +271 (c 0.32 in 
CHCl3)] with the literature [>99:1 er, 
20
D][  +251 (c 0.93, CHCl3)].
6c The use of α,β-unsaturated 
γ-ketoester bearing electron-rich aryl substituents worked particularly well, forming syn-
dihydropyranones 24 and 25 in high yield with excellent levels of stereoselectivity (>95:5 dr, 
>99:1 er). However, the incorporation of aryl groups containing electron-withdrawing 
substituents led to the formation of 26 and 27 in lower yields with reduced diastereoselectivity 
(80:20 dr), although the enantioselectivity remained high in both cases (>99:1 er). A similar 
reduction in diastereoselectivity was observed by Bode and co-workers in the related NHC-
catalysed redox reaction of an α-chloroaldehyde with an α,β-unsaturated γ-ketoester bearing a 
4-bromo substituted aryl ring.6b The reaction of a methyl substituted α-aroyloxyaldehyde with 
a 2-naphthyl substituted α,β-unsaturated γ-ketoester under the previously optimised conditions 
gave the largest reduction in diastereoselectivity, with syn-28 and anti-29 formed as a 50:50 
mixture, although both diastereoisomers were obtained in excellent enantioselectivity (>99:1 
er). 
The dramatic reduction in diastereoselectivity observed with the 2-naphthyl substituted α,β-
unsaturated γ-ketoester was probed by treating isolated syn-dihydropyranone 28 (>95:5 dr) 
with Et3N (1.5 eq) in THF at room temperature (Scheme 3). After 16 hours, the 
dihydropyranone had epimerized into a 50:50 mixture of diastereoisomers, with both obtained 
in >99:1 er. This is consistent with the result from the initial NHC-catalysed process, 
suggesting that the initially formed syn-diastereoisomer is epimerized under the basic reaction 
conditions. In this case, it is likely that epimerisation occurs at the C(4) position and that the 
presence of conjugated electron-deficient aryl substituents in the C(6) position increases the 
propensity for deprotonation, which accounts for the reduced diastereoselectivity observed in 
these cases. However, selective epimerisation at the C(3) position adjacent to the lactone cannot 
be unambiguously ruled out.  
 
 
Scheme 3. Base-promoted epimerisation of syn-28 
2.4 Proposed mechanism 
The proposed reaction mechanism is shown in Scheme 4. Initially, the catalytically active 
free NHC is generated through deprotonation of NHC precursor 2. Nucleophilic addition of the 
free NHC 30 into the α-aroyloxyaldehyde generates adduct 31, which is likely to be the 
catalytic resting state.10b Reversible deprotonation of 31 transiently forms Breslow 
intermediate 32 that can eliminate 4-nitrobenzoate. The resulting enol 33 can be deprotonated 
to form the key azolium enolate intermediate 34, which can undergo an enantioselective 
asynchronous endo-hetero-Diels-Alder reaction with an appropriate unsaturated ketoester. 
Finally, elimination from intermediate 35 releases the product syn-dihydropyranone and 
regenerates the free NHC catalyst. This mechanistic proposal is consistent with the 
computational studies from Bode and co-workers on related NHC-catalysed [4+2]-hetero-
Diels-Alder processes.15  
 
 
Scheme 4. Proposed reaction mechanism 
3 Conclusion 
α-Aroyloxyaldehydes are efficient azolium enolate precursors in enantioselective NHC-
catalysed [4+2] hetero-Diels-Alder reactions with unsaturated ketoesters. Reactions using 
either β,γ-unsaturated α-ketoesters or α,β-unsaturated γ-ketoesters form the corresponding syn-
dihydropyranone products with generally high diastereoselectivity and excellent 
enantioselectivity. In cases where the unsaturated ketoester bears an electron-deficient aryl 
substituent, the initially-formed syn-dihydropyranones are more susceptible to epimerisation at 
the C(4)-position under the reaction conditions, which lowers the observed diastereoselectivity 
of the products.  
4 Experimental  
4.1 General 
Anhydrous reactions were carried out in flame-dried glassware under an inert atmosphere 
(N2 or Ar) using standard vacuum line techniques. Anhydrous THF and Et2O were obtained 
after passing through an alumina column (Mbraun SPS-800). Petrol is defined as petroleum 
ether 40-60 °C. All other solvents and commercial reagents were used as received without 
further purification. α-Aroyloxyaldehydes were prepared according to previously reported 
procedures.10 
Room temperature (rt) refers to 20-25 °C and a temperature of 0 °C was obtained using an 
ice/water bath. Reaction involving heating were performed using DrySyn blocks and a contact 
thermocouple. Under reduced pressure refers to the use of a rotary evaporator with vacuum 
controller.  
Analytical thin layer chromatography was performed on pre-coated aluminium plates 
(Kieselgel 60 F254 silica) and visualisation was achieved using ultraviolet light (254 nm) and/or 
staining with a 1% aqueous KMnO4 solution. Flash column chromatography was performed 
on Kieselgel 60 silica in the solvent system stated. 
Melting points were recorded on an Electrothermal 9100 melting point apparatus, (dec) refers 
to decomposition. Optical rotations were measured on a Perkin Elmer Precisely/Model-341 
polarimeter operating at the sodium D line with a 100 mm path cell at 20 °C. 
HPLC analyses were obtained on either a Gilson HPLC consisting of a Gilson 305 pump, 
Gilson 306 pump, Gilson 811C dynamic mixer, Gilson 805 manometric module, Gilson 401C 
dilutor, Gilson 213XL sample injector and sample detection was performed with a Gilson 118 
UV/vis detector or a Shimadzu HPLC consisting of a DGU-20A5 degasser, LC-20AT liquid 
chromatography SIL-20AHT autosampler, CMB-20A communications bus module, SPD-
M20A diode array detector and a CTO-20A column oven. Separation was achieved using 
Chiralcel OD-H and OJ-H columns or a Chiralpak AD-H column. All HPLC traces were 
compared with an authentic racemic spectrum prepared in analogous fashion using (±)-2.  
Infrared spectra (νmax) were recorded on a Shimadzu IRAffinity-1 Fourier transform IR 
spectrophotometer using either thin film or solid using Pike MIRacle ATR accessory.  
1H, 13C{1H}, and 19F{1H} NMR spectra were acquired on either a Bruker Avance 300 (1H 
300 MHz; 13C{1H} 75 MHz; 19F{1H} 282 MHz), a Bruker Avance II 400 (1H 400 MHz; 
13C{1H} 100 MHz; 19F{1H} 376 MHz), or a Bruker Ultrashield 500 (1H 500 MHz) 
spectrometer at room temperature in the deuterated solvent stated. All chemical shifts are 
quoted in parts per million (ppm) relative to the residual solvent peak. All coupling constants, 
J, are quoted in Hz. Multiplicities are indicated as s (singlet), d (doublet), t (triplet), q (quartet), 
m (multiplet), and multiples thereof. The abbreviation Ar denotes aromatic and app denotes 
apparent. 
High resolution mass spectrometry (m/z) data was acquired by electrospray ionisation (ESI), 
atmospheric pressure chemical ionisation (APCI) or nanospray ionisation (NSI) at the EPSRC 
UK National Mass Spectrometry Facility at Swansea University. 
4.2 General procedure for the synthesis of β,γ-unsaturated α-ketoesters 
Part 1: Based upon a literature procedure procedure,16 KOH (1.5 eq) in MeOH (6 M) was 
added to a solution of pyruvic acid (1.0 eq), the required aryl aldehyde (1.0 eq) and MeOH (12 
M) at 0 °C. The first equivalent of KOH solution was added dropwise over 30 min, the rest was 
added as one portion. The reaction mixture was heated at 40 °C for 1 h before being cooled to 
0 °C and stirred overnight. The precipitate was collected by filtration and washed with cold 
MeOH (×2) and Et2O before being dried under vacuum to give the desired β,γ-unsaturated α-
ketoacid potassium salt. 
Part 2: Based upon a literature procedure procedure,17 acetyl chloride (11.5 eq) was added 
dropwise to the appropriate alcohol (0.2 M) at 0 °C before the required potassium salt (1.0 eq) 
was added. The reaction mixture was warmed to rt and stirred for 2 h before being heated at 
reflux for 6 h. The solution was cooled to rt, concentrated under reduced pressure and then 
partitioned between CH2Cl2 and H2O. The layers were separated and the aqueous layer 
extracted with CH2Cl2 (×2). The combined organic phases were washed with a saturated 
NaHCO3 solution and H2O before being dried over Na2SO4, filtered and concentrated to give 
the crude β,γ-unsaturated α-ketoester that was purified by column chromatography. 
4.2.1 (E)-Methyl 2-oxo-4-phenylbut-3-enoate 8 
Following General Procedure 4.2 (part 1), KOH (16.8 g, 300 mmol) in MeOH (60 mL), 
pyruvic acid (13.8 mL, 200 mmol) and benzaldehyde (20.4 mL, 200 mmol) in MeOH (15 mL) 
were reacted to give potassium (E)-2-oxo-4-phenylbut-3-enoate (39.0 g, 91%) as a yellow solid 
with spectroscopic data in accordance with the literature.18 mp 246–248 °C {Lit.18 248 °C}; 1H 
NMR (400 MHz, D2O) δH: 6.78 (1H, d, J 15.0, PhCH=CH), 7.34–7.42 (3H, m, Ar(3,4,5)H), 
7.39 (1H, d, J 15.0, C PhCH=CH), 7.57–7.61 (2H, m, Ar(2,6)H). 
Following General Procedure 4.2 (part 2), potassium (E)-2-oxo-4-phenylbut-3-enoate (7.48 
g, 35 mmol) and acetyl chloride (28.6 mL, 402 mmol) in MeOH (200 mL) were reacted. The 
crude was purified by column chromatography (90:10 petrol : EtOAc), then recrystallised from 
MeOH to give 8 (1.16 g, 17%) as a yellow crystalline solid with spectroscopic data in 
accordance with the literature.18 mp 69–71 °C {Lit.18 69–70 °C}; 1H NMR (300 MHz, CDCl3) 
δH: 3.94 (3H, s, OCH3), 7.38 (1H, d, J 16.1, HC=C), 7.42–7.49 (3H, m, ArH), 7.61–7.67 (2H, 
m, ArH), 7.89 (1 H, d, J 16.2, HC=C). 
4.2.2 (E)-Ethyl 2-oxo-4-(p-tolyl)but-3-enoate 36 
Following General Procedure 4.2 (part 1), KOH (1.40 g, 24.9 mmol) in MeOH (5 mL), 
pyruvic acid (1.15 mL, 16.6 mmol) and p-tolualdehyde (1.96 mL, 16.6 mmol) in MeOH (2 
mL) were reacted to give potassium (E)-2-oxo-4-(p-tolyl)but-3-enoate (2.78 g, 12.2 mmol, 
73%) as yellow solid, with spectroscopic data in accordance with the literature.18 mp 242–244 
°C (dec); 1H NMR (400 MHz, D2O) δH: 2.28 (3H, s, ArCH3), 6.74 (1H, d, J 16.4, ArCH=CH), 
7.23 (2H, d, J 8.1, ArH), 7.51 (2H, d, J 8.2, ArH), 7.59 (1H, d, J 16.4, ArCH=CH). 
Following General Procedure 4.2 (part 2), potassium (E)-2-oxo-4-(p-tolyl)but-3-enoate (1.00 
g, 4.38 mmol) and acetyl chloride (3.58 mL, 50.4 mmol) in ethanol (30 mL) were reacted. The 
crude was purified by column chromatography (95:5 petrol : EtOAc) to give 36 (0.560 g, 58%) 
as a yellow solid, with spectroscopic data in accordance with the literature.17 mp 40–42 °C 
{Lit.17 47–48 °C}; 1H NMR (300 MHz, CDCl3) δH: 1.41 (3H, t, J 7.1, OCH2CH3), 2.40 (3H, s, 
ArCH3), 4.39 (2H, q, J 7.1, OCH2CH3), 7.23 (2H, d, J 7.9, ArH), 7.32 (1H, d, J 16.1, 
ArCH=CH), 7.53 (2H, d, J 8.2, ArH), 7.84 (1H, d, J 16.1, ArCH=CH). 
4.2.3 (E)-Methyl 4-(4-methoxyphenyl)-2-oxobut-3-enoate 37 
Following General Procedure 4.2 (part 1), KOH (1.11 g, 19.8 mmol) in MeOH (4 mL), 
pyruvic acid (0.917 mL, 13.2 mmol) and p-anisaldehyde (1.80 g, 1.61 mL, 13.2 mmol) in 
MeOH (1.5 mL) were reacted to give potassium (E)-4-(4-methoxyphenyl)-2-oxobut-3-enoate 
(2.31 g, 72%) as a yellow solid, with spectroscopic data in accordance with the literature.16 mp 
250–252 °C {Lit.16 248 °C}; 1H NMR (400 MHz, D2O) δH: 6.66 (1H, d, J 16.4, CH=CH), 6.95 
(2H, d, J 8.8, ArH), 7.50–7.69 (3H, m, ArH and CH=CH). 
Following General Procedure 4.2 (part 2), potassium (E)-2-oxo-4-(4-methoxyphenyl)but-3-
enoate (2.00 g, 8.19 mmol) and acetyl chloride (6.70 mL, 94.2 mmol) in MeOH (60 mL) were 
reacted. The crude was purified by column chromatography (85:15 petrol : EtOAc) to give 37 
(1.37 g, 76%) as a yellow crystalline solid, with spectroscopic data in accordance with the 
literature.18 mp 95–96 °C {Lit.18 99–100 °C}; 1H NMR (300 MHz, CDCl3) δH: 3.80 (3H, s, 
OCH3), 3.86 (3H, s, OCH3), 6.87 (2H, d, J 8.8, ArH), 7.19 (1H, d, J 16.0, ArCH=CH), 7.54 
(2H, d, J 8.5, ArH), 7.79 (1H, d, J 16.0, ArCH=CH). 
4.2.4 (E)-Methyl 4-(4-fluorophenyl)-2-oxobut-3-enoate 38 
Following General Procedure 4.2 (part 1), KOH (1.36 g, 24.2 mmol) in MeOH (6 mL), 
pyruvic acid (1.12 mL, 16.1 mmol) and 4-fluorobenzaldehyde (2.00 g, 1.73 mL, 16.1 mmol) 
in MeOH (2 mL) were reacted to give potassium (E)-4-(4-fluorophenyl)-2-oxobut-3-enoate 
(2.67 g, 71%) as a yellow solid, with spectroscopic data in accordance with the literature.19 mp 
205–208 °C (dec); 1H NMR (500 MHz, D2O) δH: 6.73 (1H, d, J 16.3, ArCH=CH), 7.11 (2H, t, 
J 8.2, ArC(2)H), 7.59 (1H, d, J 16.4, ArCH=CH), 7.64 (2H, dd, J 7.4, 5.2, ArC(3)H); 19F NMR 
(376 MHz, D2O) δF: –109.0 (ArC(4)F). 
Following General Procedure 4.2 (part 2), potassium (E)-4-(4-fluorophenyl)-2-oxobut-3-
enoate (1.00 g, 4.31 mmol) and acetyl chloride (3.53 mL, 49.6 mmol) in MeOH (40 mL) were 
reacted. The crude was purified by column chromatography (95:5 petrol : EtOAc) to give (E)-
methyl 4-(4-fluorophenyl)-2-oxobut-3-enoate (0.320 g, 36%) as a yellow crystalline solid, with 
spectroscopic data in accordance with the literature.20 mp 86–87 °C; νmax (solid) 1722 (C=O), 
1690 (C=O); 1H NMR (400 MHz, CDCl3) δH: 3.87 (3H, s, OCH3), 7.06 (2H, t, J 8.6, ArC(3)H), 
7.25 (1H, dd, J 16.2, 0.6, CH=CH), 7.58 (2H, dd, J 8.7, 5.4, ArC(2)H), 7.78 (1H, d, J 16.1, 
CH=CH); 19F NMR (376 MHz, CDCl3) δF: –107.3 (tt, J 8.1, 5.5, C(4)F); 13C{1H} NMR (101 
MHz, CDCl3) δC: 53.1 (OCH3), 116.4 (d, J 22.0, C(3)), 120.1 (d, J 2.2, ArCH=CH), 130.3 (d, 
J 3.1, C(1)), 131.2 (d, J 8.8, C(2)), 147.2 (ArCH=CH), 162.5 (CO2), 164.7 (d, J 253.9, C(4)), 
182.1 (CH=CHCO); HRMS (NSI+) C11H10O3F [M+H]
+ found 209.0610, requires 209.0608 
(+0.7 ppm). 
4.2.5 (E)-Methyl 4-(4-bromophenyl)-2-oxobut-3-enoate 39 
Following General Procedure 4.2 (part 1), KOH (4.55 g, 81.1 mmol) in MeOH (15 mL), 
pyruvic acid (3.81 mL, 54.1 mmol) and 4-bromobenzaldehyde (10.0 g, 54.1 mmol) in MeOH 
(15 mL) were reacted to give potassium (E)-2-oxo-4-(4-bromophenyl)but-3-enoate (15.9 g, 
84%) as a yellow solid, with spectroscopic data in accordance with the literature.18 mp 240 °C 
(dec) {Lit.18 233 °C}; 1H NMR (400 MHz, D2O) δH: 6.91 (1H, d, J 17.1, C(3)H), 7.59–7.60 
(2H, m, Ar(3,5)H), 7.62 (1H, d, J 17.1, C(4)H), 7.65–7.68 (2H, m, Ar(2,6)H). 
Following General Procedure 4.2 (part 2), potassium (E)-2-oxo-4-(4-bromophenyl)but-3-
enoate (2.00 g, 6.82 mmol) and acetyl chloride (5.57 mL, 78.4 mmol) in MeOH (40 mL) were 
reacted. The crude was purified by column chromatography (95:5 petrol : EtOAc) to give 39 
(1.21 g, 66%) as a yellow crystalline solid, with spectroscopic data in accordance with the 
literature.18 mp 109–112 °C {Lit.18 120 °C}; 1H NMR (400 MHz, CDCl3) δH: 3.87 (3H, s, 
OCH3), 7.31 (1H, d, J 16.1, ArCH=CH), 7.43 (2H, d, J 8.5, ArH), 7.50 (2H, d, J 8.5, ArH), 
7.74 (1H, d, J 16.1, ArCH=CH). 
4.2.6 (E)-Methyl 4-(naphthalen-2-yl)-2-oxobut-3-enoate 40 
Following General Procedure 4.2 (part 1), KOH (1.08 g, 19.2 mmol) in MeOH (3 mL), 
pyruvic acid (0.890 mL, 12.8 mmol) and 2-naphthaldehyde (2.00 g, 12.8 mmol) in MeOH (3 
mL) were reacted to give potassium (E)-4-(naphthalen-2-yl)-2-oxobut-3-enoate (2.46 g, 73%) 
as a yellow solid, with spectroscopic data in accordance with the literature.18 mp >320 °C 
{Lit.18 270–272 °C (dec)}; 1H NMR (400 MHz, D2O) δH: 6.85 (1H, d, J 16.5, ArCH=CH), 7.50 
(2H, s, ArH), 7.65–7.74 (2H, m, ArH, and ArCH=CH), 7.81–7.86 (3H, m, ArH), 7.99 (1H, s, 
Ar(1)H). 
Following General Procedure 4.2 (part 2), potassium (E)-4-(naphthalen-2-yl)-2-oxobut-3-
enoate (1.00 g, 3.78 mmol) and acetyl chloride (3.08 mL, 43.5 mmol) in MeOH (30 mL) were 
reacted. The crude was purified by column chromatography (95:5 petrol : EtOAc) to give 40 
(0.570 g, 63%) as a yellow solid, with spectroscopic data in accordance with the literature.18 
mp 94–96 °C {Lit.18 70–72 °C}; 1H NMR (400 MHz, CDCl3) δH: 3.96 (3H, s, OCH3), 7.49 
(1H, d, J 16.1, ArCH=CH), 7.52–7.61 (2H, m, ArH), 7.77 (1H, dd, J 8.6, 1.8, ArH), 7.84–7.93 
(3H, m, ArH), 8.02–8.09 (2H, m, ArCH=CH and ArH). 
4.3 General procedure for the NHC-catalysed redox hetero-Diels-Alder reaction with 
β,γ-unsaturated α-ketoesters 
The appropriate α-aroyloxyaldehyde (1.5 eq), β,γ-unsaturated α-ketoester (1.0 eq) and NHC 
precatalyst 2 (10 mol%) were dissolved in anhydrous THF (0.075 M) in a sealed vial containing 
3Å molecular sieves. The solution was cooled to 0 °C before Et3N (1.5 eq.) was added. The 
reaction stirred, allowing to warm to rt, until complete by TLC analysis. The mixture was 
diluted with EtOAc and washed successively with 1 M HCl, saturated NaHCO3 and brine. The 
organic layer was dried with MgSO4, filtered and concentrated under reduced pressure to give 
the crude product, which was purified by column chromatography. 
4.3.1 (3S,4S)-Methyl 3-benzyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 9 
Following General Procedure 4.3, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (50 mg, 0.17 
mmol), (E)-methyl 2-oxo-4-phenylbut-3-enoate 8 (21.0 mg, 0.11 mmol), NHC precatalyst 2 
(4.0 mg, 11 mol), Et3N (23 L, 0.17 mmol) and THF (3 mL) were reacted for 12 h. The crude 
(>95:5 dr) was purified by column chromatography (90:10 petrol : EtOAc) to give 9 (51 mg, 
93%) as a colourless solid. mp 106–107 C; 20
D
][  398 (c 0.23, CHCl3); Chiral HPLC analysis, 
Chiralpak AD-H (90:10 hexane : IPA, flow rate 1.0 mLmin–1, 254 nm, 30 C) tR (R,R) 18.0 
min, tR (S,S) 27.8 min, >99:1 er; max (KBr, cm–1) 2956, 2925, 1765, 1628, 1664, 1602, 1495, 
1435, 1316, 1100; 1H NMR (400 MHz, CDCl3) H: 2.33 (1H, dd, J 10.6, 15.8, C(3)CHAHB), 
3.16–3.23 (2H, m, C(3)CHAHB and C(3)H), 3.55 (1H, t, J 6.8, C(4)H), 3.77 (3H, OCH3), 6.58 
(1H, d, J 6.7, C(5)H), 6.93–7.00 (4H, m, C(3)ArH), 7.15–7.26 (6H, m, C(3)ArH and 
C(3)CH2ArH); 
13C{1H} NMR (75 MHz, CDCl3) C: 32.1 (C(3)CH2), 40.6 (C(3)H), 44.8 
(C(4)H), 52.7 (OCH3), 118.8 (C(5)), 126.8 (C(3)CH2ArC(4)), 128.4 (C(4)ArC(4)), 128.4 
(ArC), 128.7 (ArC), 128.9 (ArC), 129.2 (ArC), 135.8 (CPh-1), 138.1 (C(3)CH2ArC(1)), 141.9 
(C(6)), 161.0 (CO2Me), 168.5 (C(2)); HRMS (ESI+) C20H22O4N [M+NH4]
+ found 340.1544, 
requires 340.1543 ( 0.2 ppm). 
4.3.2 (3S,4S)-Methyl 3-butyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 10 
Following General Procedure 4.3, 1-oxohexan-2-yl 4-nitrobenzoate (50 mg, 0.19 mmol), (E)-
methyl 2-oxo-4-phenylbut-3-enoate 8 (25.2 mg, 0.13 mmol), NHC precatalyst 2 (4.2 mg, 10.0 
μmol), Et3N (28 μL, 0.19 mmol) and THF (3 mL) were reacted for 3 h. The crude (>95:5 dr) 
was purified by column chromatography (95:5 petrol : EtOAc) to give 10 (26 mg, 69%) as a 
colourless oil. 20
D
][  156 (c 0.15, CHCl3); Chiral HPLC analysis, Chiralpak AD-H (95:5 
hexane : IPA, flow rate 1.0 mLmin–1, 220 nm) tR (R,R) 16.2 min, tR (S,S) 18.3 min, 98:2 er; 
max (ATR, cm–1) 2954, 1773, 1734, 1661, 1454, 1437, 1323, 1259, 1045; 1H NMR (300 MHz, 
CDCl3) H: 0.81 (3H, t, J 7.1, CH2CH3), 1.08–1.40 (5H, m, CH2 ×2 and C(3)CHAHB), 1.60–
1.70 (1H, m, C(3)CHAHB), 2.79 (1H, d, J 6.9, C(3)H), 3.79 (1H, t, J 6.7, C(4)H), 3.83 (3H, s, 
OCH3), 6.68 (1H, d, J 6.4, C(5)H), 7.06 (2H, dt, J 1.8, 5.8, ArC(2)H), 7.23–7.29 (3H, m, 
ArC(3)H and ArC(4)H); 13C{1H} NMR (100 MHz, CDCl3) 13.9 (CH3), 22.5 (CH2), 26.0 (CH2), 
29.4 (CH2), 41.5 (C(4)), 43.4 (C(3)), 52.7 (OCH3), 118.4 (C(5)), 128.1 (CPhH-2,6), 128.1 
(CPh-4), 129.1 (ArC(3)), 136.0 (ArC(1)), 142.1 (C(6)), 161.1 (CO2Me), 168.8 (C(2)); HRMS 
(ESI+) C17H24O4N [M+NH4]
+ found 306.1702, requires 306.1700 ( 0.7 ppm). 
4.3.3 (3S,4S)-Methyl 3-isobutyl-2-oxo-4-phenyl-3,4-dihydro-2H-pyran-6-carboxylate 
11 
Following General Procedure 4.3, 4-methyl-1-oxopentan-2-yl 4-nitrobenzoate 7 (133 mg, 
0.50 mmol), (E)-methyl 2-oxo-4-phenylbut-3-enoate 8 (63.0 mg, 0.33 mmol), NHC precatalyst 
2 (12.0 mg, 33 mol), Et3N (70 L, 0.50 mmol) and THF (5 mL) were reacted for 24 h. The 
crude (>95:5 dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 11 (60 
mg, 63%) as a colourless oil. 20
D
][  279 (c 0.14, CHCl3); Chiral HPLC analysis, Chiralpak 
AD-H (95:5 hexane : IPA, flow rate 1.0 mLmin–1, 220 nm) tR (R,R) 11.9 min, tR (S,S) 13.0 min, 
>99:1 er; max (KBr, cm–1) 2959, 1769, 1708, 1661, 1317, 1265, 1094, 1082; 1H NMR (300 
MHz, CDCl3) H: 0.83 (3H, d, J 6.6, CH3), 0.88 (3H, d, J 6.6, CH3), 1.04 (1H, app dt, J 7.0, 
14.0, i-BuCH), 1.56 (2H, dt, J 7.0, 13.9, C(3)CHAHB), 1.72 (1H, dd, J 7.0, 14.0, C(3)CHaHa), 
2.93 (1H, app q, J 6.9, C(3)H), 3.77 (1H, t, J 6.7, C(4)H), 3.87 (3H, s, OCH3), 6.72 (1H, d, J 
6.4, C(5)H), 7.07–7.10 (2H, dt, J 1.8, 5.8, ArC(2)H), 7.27–7.34 (3H, m, ArC(3)H and 
ArC(4)H); 13C{1H} NMR (100 MHz, CDCl3) C: 22.2 ((CH3)2CH), 22.5 ((CH3)2CH), 25.2 
((CH3)2CH), 35.2 (C(3)CH2), 41.2 (C(3)), 41.7 (C(4)), 52.7 (OCH3), 118.4 (C(5)), 128.1 
(ArC(2)), 128.1 (ArCC(4)), 129.1 (ArCC(3)), 136.0 (ArC(1)), 142.1 (C(6)), 161.1 (CO2Me), 
168.9 (C(2)); HRMS (ESI+) C17H24O4N, [M+NH4]
+ found 306.1704; requires 306.1700 ( 1.4 
ppm). 
4.3.4 (3S,4S)-Ethyl 3-benzyl-2-oxo-4-(p-tolyl)-3,4-dihydro-2H-pyran-6-carboxylate 12 
Following General Procedure 4.3, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (202 mg, 
0.675 mmol), (E)-ethyl 4-(p-tolyl)-2-oxobut-3-enoate 36 (98.2 mg, 0.450 mmol), NHC 
precatalyst 2 (16.6 mg, 45.0 μmol), Et3N (94.1 μL, 0.675 mmol) and THF (10 mL) were reacted 
for 12 h. The crude (94:6 dr) was purified by column chromatography (95:5 petrol : EtOAc) to 
give 12 (122 mg, 77%) as a pale yellow oil, with spectroscopic data in accordance with the 
literature.6b 20
D
][  +299.4 (c 0.5, CHCl3) {Lit.
6b 20
D
][  +310.3 (c 1.0, CHCl3)}; Chiral HPLC 
analysis, Chiralcel OD-H (90:10 hexane : IPA, flow rate 0.5 mLmin–1, 254 nm, 30 °C) tR 
(3R,4R): 19.7 min, tR (3S,4S): 23.5 min, 96:4 er; νmax (film, cm–1) 2981, 1773, 1732; 1H NMR 
(400 MHz, CDCl3) δH: 1.34 (3H, t, J 7.1, OCH2CH3), 2.36 (3H, s, C(4)ArC(4)CH3), 2.43 (1H, 
dd, J 15.8, 10.5, C(3)H), 3.22–3.32 (2H, m, C(3)CH2), 3.60 (1H, t, J 6.8, C(4)H), 4.31 (2H, q, 
J 7.1, OCH2CH3), 6.66 (1H, d, J 6.7, C(5)H), 6.93 (2H, d, J 8.1, C(3)CH2ArC(2)H), 7.09 (2H, 
d, J 6.8, C(4)ArC(2)H), 7.16 (2H, d, J 7.8, C(4)ArC(3)H), 7.21–7.36 (3H, m, C(3)CH2ArC(3)H 
and C(3)CH2ArC(4)H); 
13C{1H} (100 MHz, CDCl3) δC: 14.2 (OCH2CH3), 21.1 
(C(4)ArC(4)CH3), 32.1 (C(3)CH2), 40.2 (C(4)), 44.9 (C(3)), 61.9 (OCH2CH3), 118.8 (C(5)), 
126.7 (C(3)CH2ArC(4)), 128.3 (C(3)CH2ArC(3)), 128.6 (C(3)CH2ArC(2)), 129.0 
(C(4)ArC(2)), 129.9 (C(4)ArC(3)), 132.7 (C(4)ArC(1)), 138.1 (C(4)ArC(4)), 138.2 
(C(3)CH2ArC(4)), 141.9 (C(6)), 160.5 (CO2Et), 168.7 (C(2)). 
4.3.5 (3S,4S)-Methyl 3-benzyl-4-(4-methoxyphenyl)-2-oxo-3,4-dihydro-2H-pyran-6-
carboxylate 13 
Following General Procedure 4.3, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (202 mg, 
0.675 mmol), (E)-methyl 4-(4-methoxyphenyl)-2-oxobut-3-enoate 37 (99.1 mg, 0.450 mmol), 
NHC precatalyst 2 (16.6 mg, 45.0 μmol), Et3N (94.1 μL, 0.675 mmol) and THF (10 mL) were 
reacted for 16 h. The crude (91:9 dr) was purified by column chromatography (90:10 petrol : 
EtOAc) to give 13 (98.3 mg, 62%) as a pale yellow oil. 20
D
][  +277.3 (c 0.5, CHCl3); Chiral 
HPLC analysis, Chiralcel OD-H (90:10 hexane : IPA, flow rate 0.5 mLmin–1, 220 nm, 30 °C) 
tR (3R,4R): 40.7 min, tR (3S,4S): 45.0 min, >99:1 er; νmax (film, cm–1) 2955, 1771, 1734; 1H 
NMR (300 MHz, CDCl3) δH: 2.41 (1H, dd, J 15.7, 10.6, C(3)H), 3.21–3.30 (2H, m, C(3)CH2), 
3.58 (1H, t, J 6.7, C(4)H), 3.80 (3H, s, OCH3), 3.84 (3H, s, CO2CH3), 6.65 (1H, d, J 6.8, C(5)H), 
6.86 (2H, d, J 8.8, C(4)ArC(2)H), 6.93 (2H, d, J 8.8, C(4)ArC(3)H), 7.04–7.11 (2H, m, 
C(3)CH2ArC(2)H), 7.20–7.35 (3H, m, C(3)CH2ArC(3)H and C(3)CH2ArC(4)H); 13C{1H} 
NMR (100 MHz, CDCl3) δC: 30.9 (C(3)CH2), 38.7 (C(4)), 43.9 (C(3)), 51.6 (CO2CH3), 54.3 
(C(4)ArC(4)OCH3), 113.5 (C(4)ArC(2)), 118.1 (C(5)), 125.7 (C(3)CH2ArC(1)), 126.4 
(C(4)ArC(1)), 127.6 (C(3)CH2ArC(3)), 127.9 (C(3)CH2ArC(2)), 128.9 (C(4)ArC(3)), 137.1 
(C(3)CH2ArC(1)), 140.5 (C(6)), 158.5 (C(4)ArC(4)), 160.0 (CO2Me), 167.6 (C(2)); HRMS 
(NSI+) C21H24O5N1 [M+NH4]
+ found 370.1655, requires 370.1649 (+1.6 ppm). 
4.3.6 (3S,4S)-Ethyl 3-butyl-2-oxo-4-(p-tolyl)-3,4-dihydro-2H-pyran-6-carboxylate 14 
Following General Procedure 4.3, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.750 mmol), 
(E)-ethyl 2-oxo-4-(p-tolyl)but-3-enoate 36 (109 mg, 0.500 mmol), NHC precatalyst 2 (18.4 
mg, 50.0 μmol), Et3N (105 μL, 0.750 mmol) and THF (10 mL) were reacted for 9 h. The crude 
(92:8 dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 14 (110 mg, 
70%) as a pale yellow oil. 20
D
][  +249.2 (c 0.5, CHCl3); Chiral HPLC analysis, Chiralpak AD-
H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 °C) tR (3S,4S): 11.3 min, tR (3R,4R): 
13.7 min, >99:1 er; νmax (film, cm–1) 2957, 1773, 1732; 1H NMR (400 MHz, CDCl3) δH: 0.78 
(3H, t, J 7.2, CH2CH3), 1.04–1.38 (7H, m, (CH2)2 and OCH2CH3), 1.54–1.71 (2H, m, CH2), 
2.24 (3H, s, ArC(4)CH3), 2.73 (1H, q, J 7.0, C(3)H), 3.70 (1H, t, J 6.8, C(4)H), 4.24 (2H, q, J 
7.1, OCH2CH3), 6.62 (1H, d, J 6.4, C(5)H), 6.91 (2H, d, J 8.1, ArC(2)H), 7.04 (2H, d, J 7.8, 
ArC(3)H); 13C{1H} NMR (100 MHz, CDCl3) δC: 13.9 (OCH2CH3), 14.2 (CH2CH3), 21.1 
(ArC(4)CH3), 22.5 (CH2), 26.0 (CH2), 29.4 (CH2), 41.1 (C(4)), 43.4 (C(3)), 61.9 (OCH2CH3), 
118.4 (C(5)), 127.9 (ArC(2)), 129.8 (ArC(3)), 132.9 (ArC(1)), 137.9 (ArC(4)), 142.1 (C(6)), 
160.6 (CO2Et), 169.0 (C(2)); HRMS (NSI
+) C19H28O4N [M+NH4]
+ found 334.2019, requires 
334.2013 (+1.8 ppm). 
4.3.7 (3S,4S)-Methyl 3-butyl-4-(4-methoxyphenyl)-2-oxo-3,4-dihydro-2H-pyran-6-
carboxylate 15 
Following General Procedure 4.3, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.750 mmol), 
(E)-methyl 4-(4-methoxyphenyl)-2-oxobut-3-enoate 37 (110 mg, 0.500 mmol), NHC 
precatalyst 2 (18.4 mg, 50.0 μmol), Et3N (105 μL, 0.750 mmol) and THF (10 mL) were reacted 
for 14 h. The crude (92:8 dr) was purified by column chromatography (95:5 petrol : EtOAc) to 
give 15 (114 mg, 72%) as a pale yellow oil. 20
D
][  +245.1 (c 0.5, CHCl3); Chiral HPLC analysis, 
Chiralpak AD-H (90:10 hexane : IPA, flow rate 0.5 mLmin–1, 220 nm, 30 °C) tR (3S,4S): 30.5 
min, tR (3R,4R): 32.6 min, >99:1 er; νmax (film, cm–1) 2955, 1771, 1734; 1H NMR (300 MHz, 
CDCl3) δH: 0.84 (3H, t, J 7.1, CH2CH3), 1.09–1.43 (5H, m, (CH2)2 and C(3)CHAHB), 1.58–
1.76 (1H, m, C(3)CHAHB), 2.78 (1H, q, J 6.9, C(3)H), 3.73–3.80 (4H, m, ArC(4)OCH3 and 
C(4)H), 3.85 (3H, s, CO2CH3), 6.69 (1H, d, J 6.5, C(5)H), 6.83 (2H, d, J 8.7, ArC(2)H), 7.00 
(2H, d, J 8.7, ArC(3)H); 13C{1H} NMR (75 MHz, CDCl3) δC: 12.8 (CH2CH3), 21.4 (CH2), 24.9 
(CH2), 28.3 (CH2), 39.6 (C(4)), 42.5 (C(3)), 51.6 (CO2CH3), 54.3 (ArC(4)OCH3), 113.4 
(ArC(2)), 117.7 (C(5)), 126.7 (ArC(1)), 128.1 (ArC(3)), 140.8 (C(6)), 158.3 (ArC(4)), 160.1 
(CO2Me), 167.9 (C(2)); HRMS (NSI
+) C18H26O5N [M+NH4]
+ found 336.1812, requires 
336.1805 (+1.9 ppm). 
4.3.8 (3S,4S)-Methyl 4-(4-bromophenyl)-3-butyl-2-oxo-3,4-dihydro-2H-pyran-6-
carboxylate 16 
Following General Procedure 4.3, 1-oxohexan-2-yl-4-nitrobenzoate (200 mg, 0.750 mmol), 
(E)-methyl 4-(4-bromophenyl)-2-oxobut-3-enoate 39 (135 mg, 0.500 mmol), NHC precatalyst 
2 (18.4 mg, 50.0 μmol), Et3N (105 μL, 0.750 mmol) and THF (10 mL) were for 4 h. The crude 
(89:11 dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 16 (77.1 mg, 
42%) as a pale yellow oil. 20
D
][  +205.3 (c 0.5, CHCl3); Chiral HPLC analysis, Chiralpak AD-
H (95:5 hexane : IPA, flow rate 1 mLmin–1, 220 nm, 30 °C) tR (3S,4S): 15.1 min, tR (3R,4R): 
17.7 min, 99:1 er; νmax (film, cm–1) 2955, 1773, 1732; 1H NMR (300 MHz, CDCl3) δH: 0.78–
1.00 (3H, m, CH2CH3), 1.06–1.47 (5H, m, (CH2)2 and C(3)CHAHB), 1.54–1.77 (1H, m, 
C(3)CHAHB), 2.82 (1H, q, J 7.0, C(3)H), 3.79 (1H, t, J 6.7, C(4)H), 3.87 (3H, s, ArC(4)OCH3), 
6.67 (1H, d, J 6.4, C(5)H), 6.97 (2H, d, J 8.4, ArC(3)H), 7.44 (2H, d, J 8.5, ArC(2)H); 13C{1H} 
NMR (75 MHz, CDCl3) δC: 12.8 (CH2CH3), 21.4 (CH2), 24.9 (CH2), 28.3 (CH2), 39.7 (C(4)), 
42.2 (C(3)), 51.7 (CO2CH3), 116.6 (C(5)), 121.1 (ArC(4)), 128.7 (ArC(3)), 131.3 (ArC(2)), 
134.0 (ArC(1)), 141.3 (C(6)), 159.8 (CO2Me), 167.4 (C(2)); HRMS (NSI
+) C17H23BrO5N 
[M+NH4]
+ found 384.0813, requires 384.0805 (+2.1 ppm).  
4.3.9 (3S,4S)-Methyl 3-butyl-4-(naphthalen-2-yl)-2-oxo-3,4-dihydro-2H-pyran-6-
carboxylate 17 
Following General Procedure 4.3, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.750 mmol), 
(E)-methyl 4-(naphthalen-2-yl)-2-oxobut-3-enoate 40 (120 mg, 0.500 mmol), NHC precatalyst 
2 (18.4 mg, 50.0 μmol), Et3N (105 μL, 0.750 mmol) and THF (10 mL) were reacted for 6 h. 
The crude (94:6 dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 17 
(81.7 mg, 48%) as a colourless solid. mp 99–101 °C; 20
D
][  +297.0 (c 0.5, CHCl3); Chiral HPLC 
analysis, Chiralpak AD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 °C) tR (3R,4R): 
22.0 min, tR (3S,4S): 25.0 min, >99:1 er; νmax (solid) 2951, 1757, 1736; 1H NMR (400 MHz, 
CDCl3) δH: 0.83 (3H, t, J 7.3, CH2CH3), 1.11–1.49 (5H, m, (CH2)2 and C(3)CHAHB), 1.63–
1.78 (1H, m, C(3)CHAHB), 2.90 (1H, q, J 7.0, C(3)H), 3.88 (3H, s, CO2CH3), 3.99 (1H, t, J 6.7, 
C(4)H), 6.77 (1H, d, J 6.3, C(5)H), 7.19 (1H, dd, J 8.5, 1.9, ArH), 7.44–7.52 (2H, m, ArH), 
7.57 (1H, d, J 1.8, ArC(2)H), 7.74–7.85 (3H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) δC: 
12.8 (CH3CH2), 21.4 (CH2), 25.0 (CH2), 28.4 (CH2), 40.6 (C(4)), 42.4 (C(3)), 51.7 (CO2CH3), 
117.2 (C(5)), 124.5 (ArC(8)), 125.3 (ArC), 125.5 (ArC), 126.1 (ArC(2)), 126.6 (ArC(6)), 126.8 
(ArC), 127.7 (ArC(2a)), 128.0 (ArC), 131.9 (ArC(1)), 132.4 (ArC(6a)), 141.1 (C(5)), 163.3 
(CO2CH3), 167.7 (C(2)); HRMS (NSI
+) C21H26O4N1 [M+NH4]
+ found 356.1862, requires 
356.1856 (+1.6 ppm). 
4.4 General procedure for the synthesis of α,β-unsaturated γ-ketoesters 
Based upon a literature procedure,21 periodic acid (1 eq.) was added portionwise to a solution 
of (+)-diethyl L-tartrate (1 eq.) in anhydrous Et2O (0.5 M). The solution was stirred at rt for 3 h 
before being filtered into a dried two-necked round-bottomed flask containing MgSO4 (1.0 g / 
7 mL Et2O), washing with THF (1 mL / 0.8 mL EtO). The resulting solution was cooled to 0 
°C before the appropriate phosphorane (1.5 eq.) was added in one portion. The reaction was 
stirred overnight (cf. 16 h), allowing to warm slowly to rt. The reaction was filtered and 
concentrated under reduced pressure to give the crude product, which was purified by column 
chromatography.  
4.4.1 (E)-Ethyl 4-oxopent-2-enoate 41 
Following General Procedure 4.4, periodic acid (0.95 g, 4.2 mmol) and (+)-diethyl L-tartrate 
(0.72 mL, 4.2 mmol) in Et2O (8.5 mL) were stirred for 3 h at rt. The reaction was filtered into 
a two-necked round-bottomed flask containing MgSO4 (1.0 g), washing with THF (10.5 mL), 
before 1-(triphenylphosphoranylidene)propan-2-one (2.0 g, 6.3 mmol) was added at 0 °C. The 
crude product was purified by column chromatography (80:20 hexane : Et2O, Rf 0.24) to give 
41 (0.61 g, 68%) as a colourless oil, with spectroscopic data in accordance with the literature.22 
1H NMR (300 MHz, CDCl3) H: 1.32 (3H, t, J 7.2 CH2CH3), 2.36 (3H, s, COCH3), 4.26 (2H, 
q, J 7.2, OCH2), 6.64 (1H, d, J 16.1, EtO2CCH), 7.01 (1H, d, J 16.1, CHCOMe). 
4.4.2 (E)-Ethyl 4-oxo-4-(p-tolyl)but-2-enoate 42 
Following General Procedure 4.4, periodic acid (0.39 g, 1.7 mmol) and (+)-diethyl L-tartrate 
(0.35 g, 1.7 mmol) in Et2O (3.5 mL) were stirred for 3 h at rt. The reaction was filtered into a 
two-necked round-bottomed flask containing MgSO4 (0.5 g), washing with THF (4.3 mL), 
before 1-(p-tolyl)-2-(triphenylphosphoranylidene)ethanone (1.0 g, 2.5 mmol) was added at 0 
°C. The crude product was purified by column chromatography (95:5 petrol : EtOAc, Rf 0.36) 
to give 42 (0.39 g, 78%) as a yellow oil, with spectroscopic data in accordance with the 
literature.21 1H NMR (300 MHz, CDCl3) H: 1.35 (3H, t, J 7.1, CH2CH3), 2.44 (3H, s, 
ArC(4)CH3), 4.30 (2H, q, J 7.1, OCH2), 6.87 (1H, d, J 15.6, EtO2CCH), 7.31 (2H, d, J 8.2, 
ArC(3,5)H), 7.91 (1H, d, J 15.5, CHCOAr), 7.91 (1H, d, J 8.2, ArC(2,6)H). 
4.4.3 (E)-Ethyl 4-(4-methoxyphenyl)-4-oxobut-2-enoate 43 
Following General Procedure 4.4, periodic acid (0.37 g, 1.6 mmol) and (+)-diethyl L-tartrate 
(0.34 g, 1.6 mmol) in Et2O (3.2 mL) were stirred for 3 h at rt. The reaction was filtered into a 
two-necked round-bottomed flask containing MgSO4 (0.5 g), washing with THF (4.1 mL), 
before 1-(4-methoxyphenyl)-2-(triphenylphosphoranylidene)ethanone (1.0 g, 2.4 mmol) was 
added at 0 °C. The crude product was purified by column chromatography (70:30 petrol : Et2O, 
Rf 0.25) to give 43 (0.48 g, 83%) as a yellow oil, which solidified over time, with spectroscopic 
data in accordance with the literature.21 mp 4042 °C; 1H NMR (300 MHz, CDCl3) H: 1.35 
(3H, t, J 7.2 CH2CH3), 3.90 (3H, s, OCH3), 4.30 (2H, q, J 7.1, OCH2), 6.87 (1H, d, J 15.5, 
EtO2CCH), 6.98 (2H, d, J 9.0, ArC(3,5)H), 7.92 (1H, d, J 15.5, CHCOAr), 8.01 (2H, d, J 9.0, 
ArC(2,6)H). 
4.4.4 (E)-Ethyl 4-(4-chlorophenyl)-4-oxobut-2-enoate 44 
Following General Procedure 4.4, periodic acid (0.37 g, 1.6 mmol) and (+)-diethyl L-tartrate 
(0.33 g, 1.6 mmol) in Et2O (3.2 mL) were stirred for 3 h at rt. The reaction was filtered into a 
two-necked round-bottomed flask containing MgSO4 (0.5 g), washing with THF (4.0 mL), 
before 1-(4-chlorophenyl)-2-(triphenylphosphoranylidene)ethanone (1.0 g, 2.4 mmol) was 
added at 0 °C. The crude product was purified by column chromatography (95:5 petrol : EtOAc, 
Rf 0.29) to give 44 (0.57 g, 99%) as a yellow solid, with spectroscopic data in accordance with 
the literature.21 mp 6263 ºC; 1H NMR (300 MHz, CDCl3) H: 1.35 (3H, t, J 7.1, CH3), 4.30 
(2H, q, J 7.1, OCH2), 6.90 (1H, d, J 15.5, EtO2CCH), 7.49 (2H, d, J 8.7, ArC(3,5)H), 7.87 (1H, 
d, J 15.6, CHCOAr), 7.95 (1H, d, J 8.7, ArC(2,6)H). 
4.4.5 (E)-Ethyl 4-oxo-4-(4-(trifluoromethyl)phenyl)but-2-enoate 45 
Following General Procedure 4.4, periodic acid (0.68 g, 3.0 mmol) and (+)-diethyl L-tartrate 
(0.51 mL, 3.0 mmol) in Et2O (6.0 mL) were stirred for 3 h at rt. The reaction was filtered into 
a two-necked round-bottomed flask containing MgSO4 (1.0 g), washing with THF (7.5 mL), 
before 1-(4-(trifluoromethyl)phenyl)-2-(triphenylphosphoranylidene)ethanone (2.0 g, 4.5 
mmol) was added at 0 °C. The crude product was purified by column chromatography (90:10 
petrol : Et2O, Rf 0.24) to 45 (0.85 g, 70%) as a yellow solid. mp 6163 ºC; max (film, cm–1) 
1721, 1672, 1630, 1414, 1315, 1294, 1163, 1123, 1111; 1H NMR (300 MHz, CDCl3) H: 1.35 
(3H, t, J 7.1 CH3), 4.31 (2H. q. J 7.1, OCH2), 6.91 (1H, d, J 15.6, EtO2CCH), 7.78 (2H, d, J 
8.4, ArC(3,5)H), 7.87 (1H, d, J 15.5, CHCOAr), 8.09 (2H, d, J 8.3, ArC(2,6)H); 13C{1H} NMR 
(75 MHz, CDCl3) C: 14.3 (CH3), 61.7 (OCH2), 123.6 (q, 1JCF 272.8, CF3), 126.1 (q, 3JCF 3.7, 
ArC(2)H), 129.3 (ArC(3)H), 133.8 (EtO2C=CH), 135.1 (q, 
2JCF 32.8, ArC(1)), 135.7 
(C=CHCOAr), 139.4 (ArC(4)), 165.4 (CO2Et), 188.9 (COAr); 
19F{1H} NMR (282 MHz, 
CDCl3) F: 63.69 (CF3); HRMS (APCI+) C13H12O3F3 [M+H]+ found 273.0732, requires 
273.0733 (0.4 ppm). 
4.4.6 (E)-Ethyl 4-(naphthalen-2-yl)-4-oxobut-2-enoate 46 
Following General Procedure 4.4, periodic acid (1.06 g, 4.6 mmol) and (+)-diethyl L-tartrate 
(0.80 mL, 4.6 mmol) in Et2O (9.0 mL) were stirred for 3 h at rt. The reaction was filtered into 
a two-necked round-bottomed flask containing MgSO4 (1.5 g), washing with THF (11.5 mL), 
before 1-(naphthalen-2-yl)-2-(triphenylphosphoranylidene)ethanone (3.00 g, 7.0 mmol) was 
added at 0 °C. The crude product was purified by column chromatography (80:20 hexane : 
Et2O, Rf 0.38) to give 46 (1.24 g, 70%) as a yellow solid. mp 5759 ºC; max (film, cm–1) 1717, 
1667, 1624, 1464, 1364, 1304, 1246, 1175, 1123; 1H NMR (300 MHz, CDCl3) H: 1.38 (3H, t, 
J 7.2 CH3), 4.33 (2H. q. J 7.2, OCH2), 6.96 (1H, d, J 15.5, EtO2CCH), 7.52–7.68 (2H, m, ArH), 
7.86–8.10 (4H, m, ArH), 8.09 (1H, d, J 15.5, CHCOAr), 8.46–8.55 (1H, m, ArH); 13C{1H} 
NMR (75 MHz, CDCl3) C: 14.4 (CH3), 61.6 (OCH2), 124.2 (ArC), 127.2 (ArC), 128.0 (ArC), 
129.1 (ArC), 129.2 (ArC), 129.9 (ArC), 131.3 (ArC), 132.6 (C=CCO2), 132.7 (ArC), 134.2 
(ArC), 136.0 (ArC), 136.6 (C=CCO), 165.9 (CO2), 189.4 (CO); HRMS (NSI
+) C16H15O3 
[M+H]+ found 255.1017, requires 255.1016 (+0.5 ppm). 
4.5 General procedure for the NHC-catalysed redox hetero-Diels-Alder reaction with 
α,β-unsaturated γ-ketoesters 
The appropriate α-aroyloxyaldehyde (1.5 eq), α,β-unsaturated γ-ketoester (1.0 eq) and NHC 
precatalyst 2 (5 mol%) were dissolved in anhydrous THF (0.075 M) in a sealed vial containing 
3Å molecular sieves. Et3N (1.5 eq.) was added and the reaction stirred until complete by TLC 
analysis. The mixture was diluted with EtOAc and washed successively with 1 M HCl, saturated 
NaHCO3 and brine. The organic layer was dried with MgSO4, filtered and concentrated under 
reduced pressure to give the crude product, which was purified by column chromatography. 
4.5.1 (3S,4S)-Ethyl 3-butyl-2-oxo-6-phenyl-3,4-dihydro-2H-pyran-4-carboxylate 20 
Following General Procedure 4.5, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.75 mmol), 
(E)-ethyl 4-oxo-4-phenylbut-2-enoate (102 mg, 0.500 mmol), NHC precatalyst 2 (18.4 mg, 
50.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (10 mL) were reacted for 5 h. The crude (>95:5 
dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 20 (129 mg, 85%) 
as colourless solid. mp 61–63 °C; 20
D
][  +185.5 (c 0.5, CHCl3); Chiral HPLC analysis, Chiralcel 
OJ-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 °C) tR (3S,4S): 17.2 min, tR (3R,4R): 
22.3 min, >99:1 er; νmax (solid) 2953 (C-H), 1761 (C=O), 1719 (C=O); 1H NMR (400 MHz, 
CDCl3) δH: 0.91 (3H, t, J 7.1, CH2CH3), 1.25 (3H, t, J 7.1, OCH2CH3), 1.31–1.54 (5H, m, 
(CH2)2 and C(3)CH
AHB), 1.99–2.13 (1H, m, C(3)CHAHB), 2.68–2.79 (1H, m, C(3)H), 3.53 
(1H, t, J 6.3, C(4)H), 4.17 (2H, qd, J 7.1, 2.5, OCH2CH3), 5.88 (1H, d, J 6.5, C(5)H), 7.32–
7.41 (3H, m, ArC(2)H and ArC(4)H), 7.61–7.66 (2H, m, ArC(3)H); 13C{1H} NMR (100 MHz, 
CDCl3) δC: 12.8 (CH2CH3), 13.0 (OCH2CH3), 21.5 (CH2), 25.8 (CH2), 28.3 (CH2), 39.5 (C(3)), 
40.8 (C(4)), 60.5 (OCH2CH3), 96.9 (C(5)), 123.8 (ArC(3)), 127.5 (ArC(2)), 128.4 (ArC(4)), 
130.9 (ArC(1)), 151.1 (C(6)), 168.2 (C(2)), 169.2 (CO2Et); HRMS (NSI
+) C18H26O4N 
[M+NH4]
+ found 320.1864, requires 320.1856 (+2.4 ppm). 
4.5.2 (3S,4S)-Ethyl 3-benzyl-2-oxo-6-phenyl-3,4-dihydro-2H-pyran-4-carboxylate 21 
Following General Procedure 4.5, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (238 mg, 
0.80 mmol), (E)-ethyl 4-oxo-4-phenylbut-2-enoate (108 mg, 0.53 mmol), NHC precatalyst 2 
(19.5 mg, 53 μmol), Et3N (0.11 mL, 0.80 mmol) and THF (5 mL) were reacted for 2 h. The 
crude (>95:5 dr) was purified by column chromatography (95:5 petrol : EtOAc) to give 21 (140 
mg, 79%) as a colourless oil, with spectroscopic data in accordance with the literature.6c 20
D
][  
173.0 (c 1.05, CHCl3) {Lit.6c 107.2 (c 0.82, CHCl3)}; Chiral HPLC analysis Chiralpak AD-
H (90:10 hexane : IPA, flow rate 1.0 mLmin–1, 254 nm, 30 C) >99:1 er; 1H NMR (300 MHz, 
CDCl3) H: 1.29 (3H, t, J 7.1, OCH2CH3) 2.77 (1H, dd, J 14.2, 10.2, PhCHAHB), 2.97–3.03 
(1H, m, C(3)H), 3.25 (1H, dd, J 6.9, 5.9, C(4)H) 3.55 (1H, dd, J 14.2, 4.6, PhCHAHB), 4.22 
(2H, q, J 7.1, OCH2CH3), 5.80 (1H, d, J 7.0, C(5)H), 7.16–7.21 (2H, m, ArH), 7.26–7.40 (6H, 
m, ArH), 7.60–7.63 (2H, m, ArH).  
4.5.3 (3S,4S)-Ethyl 3-(2-(benzyloxy)ethyl)-2-oxo-6-phenyl-3,4-dihydro-2H-pyran-4-
carboxylate 22 
Following General Procedure 4.5, 4-(benzyloxy)-1-oxobutan-2-yl 4-nitrobenzoate (257 mg, 
0.75 mmol), (E)-ethyl 4-oxo-4-phenylbut-2-enoate (102 mg, 0.50 mmol), NHC precatalyst 2 
(9.2 mg, 25.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) were reacted for 9 h. The 
crude (90:10 dr) was purified by column chromatography (85:15 petrol : EtOAc, Rf 0.25) to 
give 22 (161 mg, 85%) as white solid. mp 77–78 °C (hexane); 20
D
][  +169.1 (c 0.55 in CHCl3); 
Chiral HPLC analysis, Chiralcel OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 
ºC) tR (3R,4R): 23.2 min, tR (3S,4S): 25.1 min, >99:1 er; max (film, cm–1) 1767 (C=O), 1715 
(C=O), 1657 (C=C); 1H NMR (300 MHz, CDCl3) H: 1.23 (3H, t, J 7.1, OCH2CH3), 1.72–1.83 
(1H, m, C(3)CHAHB), 2.37–2.48 (1H, m, C(3)CHAHB), 3.04 (1H, q, J 6.7, C(3)H), 3.50 (1H, t, 
J 6.5, C(4)H), 3.60–3.72 (2H, m, C(3)CH2CH2), 4.09–4.20 (2H, m, OCH2CH3), 4.50 (2H, d, J 
2.1, OCH2Ar), 5.86 (1H, d, J 6.9, C(5)H), 7.27–7.40 (8H, m, ArH), 7.61–7.66 (2H, m, ArH); 
13C{1H} NMR (75 MHz, CDCl3) C: 14.2 (CH3), 27.8 (CH2), 37.6 (C(3)H), 42.1 (C(4)H), 61.7 
(OCH2CH3), 67.4 (OCH2CH2), 73.2 (OCH2Ph), 98.2 (C(5)H), 125.0 (ArCH), 127.8 (ArCH), 
128.5 (ArCH), 128.6 (ArCH), 129.6 (ArCH), 132.0 (ArC), 138.2 (ArC), 152.4 (C(6)), 169.4 
(C(2)), 170.4 (CO2Et); HRMS (NSI
+) C23H25O5 [M+H]
+ found 381.1697, requires 381.1697 
(+0.1 ppm). 
4.5.4 (3S,4S)-Ethyl 3-benzyl-6-methyl-2-oxo-3,4-dihydro-2H-pyran-4-carboxylate 23 
In a modified procedure, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (196 mg, 0.65 mmol), 
(E)-ethyl 4-oxopent-2-enoate 41 (62 mg, 0.44 mmol), NHC precatalyst 2 (8.0 mg, 21.8 mol), 
and Cs2CO3 (142 mg, 0.44 mmol) were dissolved in THF (4.4 mL) in a sealed vial and heated 
at 40 °C for 7 h. The mixture was then diluted with EtOAc and washed successively with 1 M 
HCl (×2), NaHCO3 (×2), and brine (×2) before being dried over MgSO4 and concentrated under 
reduced pressure. The crude (>95:5 dr) was purified by column chromatography (95:5 petrol : 
EtOAc, Rf 0.20) to give 23 (79 mg, 65%) as white solid, with spectroscopic data in accordance 
to the literature.6c mp 88–89 °C (hexane); 20
D
][  +270.9 (c 0.32 in CHCl3) {Lit.
6c +250.6 (c 
0.93, CHCl3)}; Chiral HPLC analysis, Chiralcel AD-H (95:5 hexane : IPA, flow rate 1 mLmin
–
1, 254 nm, 30 °C) tR (3R,4R): 11.0 min, tR (3S,4S): 13.2 min, 98.5:1.5 er; max (film, cm–1) 1771 
(C=O), 1726 (C=O), 1688 (C=C); 1H NMR (300 MHz, CDCl3) H: 1.21 (3H, t, J 7.1, 
OCH2CH3), 1.83 (3H, s, C(6)CH3), 2.61 (1H, dd, J 14.3, 10.1, C(3)CH
AHB), 2.75–2.82 (1H, 
m, C(3)H), 2.92 (1H, t, J 6.4, C(4)H), 3.42 (1H, dd, J 14.2, 4.6, C(3)CHAHB), 4.13 (2H, q, J 
7.2, OCH2), 4.95 (1H, dd, J 6.8, 1.1, C(5)H), 7.04–7.10 (2H, m, ArC(2)H), 7.12–7.27 (3H, m, 
ArC(3)H and ArC(4)H); 13C{1H} NMR (75 MHz, CDCl3) C: 14.2 (CH2CH3), 18.9 (CCH3), 
33.3 (CH2), 40.4 (C(3)H), 42.8 (C(4)H), 61.5 (OCH2), 98.7 (C(5)H), 126.9 (ArCH), 128.8 
(ArCH), 129.1 (ArCH), 138.3 (ArC), 152.4 (C(6)), 169.3 (C(2)), 170.7 (CO2Et); HRMS (NSI
+) 
C16H19O4 [M+H]
+ found 275.1280, requires 275.1278 (+0.8 ppm). 
4.5.5 (3S,4S)-Ethyl 3-butyl-2-oxo-6-(p-tolyl)-3,4-dihydro-2H-pyran-4-carboxylate 24 
Following General Procedure 4.5, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.75 mmol), 
(E)-ethyl 4-oxo-4-(p-tolyl)but-2-enoate 42 (109 mg, 0.50 mmol), NHC precatalyst 2 (9.2 mg, 
25.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) were reacted for 6 h. The crude (>95:5 
dr) was purified by column chromatography (90:10 hexane : Et2O, Rf 0.19) to give 24 (127 mg, 
80%) as colourless needles. mp 64–65 °C (hexane); 20
D
][  +158.4 (c 0.38 in CHCl3); Chiral 
HPLC analysis, Chiralcel OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 ºC) tR 
(3S,4S): 8.3 min, tR (3R,4R): 9.0 min, >99:1 er; max (film, cm–1) 1763 (C=O), 1719 (C=O), 
1684 (C=C); 1H NMR (300 MHz, CDCl3) H: 0.91 (3H, t, J 7.1, (CH2)3CH3), 1.25 (3H, t, J 7.2, 
OCH2CH3), 1.31–1.52 (5H, m, C(3)HaHb and CH2 ×2), 1.98–2.15 (1H, m, C(3)HaHb), 2.36 
(3H, s, ArC(4)CH3), 2.73 (1H, q, J 6.5, C(3)H), 3.51 (1H, t, J 6.3, C(4)H), 4.17 (2H, qd, J 7.2, 
1.9, OCH2), 5.82 (1H, d, J 6.5, C(5)H), 7.18 (2H, d, J 8.1, ArC(3)H), 7.53 (2H, d, J 8.3, 
ArC(2)H); 13C{1H} NMR (75 MHz, CDCl3) C: 14.0 (CH3), 14.2 (CH3), 21.4 (CH3), 22.6 
(CH2), 26.9 (CH2), 29.5 (CH2), 40.7 (C(3)H), 42.0 (C(4)H), 61.6 (OCH2), 97.1 (C(5)H), 124.9 
(ArC), 129.2 (ArCH), 129.3 (ArCH), 139.7 (ArC), 152.4 (C(6)), 169.6 (C(2)), 170.5 (CO2Et); 
HRMS (NSI+) C19H25O4 [M+H]
+ found 317.1751, requires 317.1747 (+1.1 ppm). 
4.5.6 (3S,4S)-Ethyl 3-butyl-6-(4-methoxyphenyl)-2-oxo-3,4-dihydro-2H-pyran-4-
carboxylate 25 
Following General Procedure 4.5, 1-oxohexan-2-yl 4-nitrobenzoate (200 mg, 0.75 mmol), 
(E)-ethyl 4-(4-methoxyphenyl)-4-oxobut-2-enoate 43 (117 mg, 0.50 mmol), NHC precatalyst 
2 (9.2 mg, 25.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) were reacted for 6 h. The 
crude (>95:5 dr) was purified by column chromatography (85:15 hexane : Et2O, Rf 0.17) to 
give 25 (149 mg, 90%) as white solid. mp 61–62 °C (hexane); 20
D
][  +123.6 (c 0.39 in CHCl3); 
Chiral HPLC analysis, Chiralcel OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 
ºC) tR (3R,4R): 13.9 min, tR (3S,4S): 14.5 min, >99:1 er; max (film, cm–1) 1751 (C=O), 1726 
(C=O), 1661 (C=C); 1H NMR (300 MHz, CDCl3) H: 0.91 (3H, t, J 7.1, CH2CH3), 1.25 (3H, t, 
J 7.2, OCH2CH3), 1.31–1.49 (5H, m, C(3)HaHb), 1.99–2.11 (1H, m, C(3)HaHb), 2.72 (1H, q, J 
6.5, C(3)H), 3.50 (1H, t, J 6.3, C(4)H), 3.82 (3H, s, ArC(4)OCH3), 4.17 (2H, qd, J 7.1, 1.9, 
OCH2), 5.74 (1H, d, J 6.5, C(5)H), 6.89 (2H, d, J 8.9, ArC(3)H), 7.57 (2H, d, J 9.0, ArC(2)H); 
13C{1H} NMR (75 MHz, CDCl3) C: 14.0 (CH3), 14.2 (CH3), 22.6 (CH2), 26.9 (CH2), 29.5 
(CH2), 40.8 (C(3)H), 41.9 (C(4)H), 55.5 (OCH3), 61.6 (OCH2), 96.0 (C(5)H), 114.0 (ArC), 
124.6 (ArCH), 126.4 (ArCH), 152.1 (C(6)), 160.7 (ArC), 169.6 (C(2)), 170.6 (CO2Et); HRMS 
(NSI+) C19H25O5 [M+H]
+ found 333.1699, requires 333.1697 (+0.7 ppm). 
4.5.7 (3S,4S)-Ethyl 6-(4-chlorophenyl)-3-methyl-2-oxo-3,4-dihydro-2H-pyran-4-
carboxylate 26 
Following General Procedure 4.5, 1-oxopropan-2-yl 4-nitrobenzoate (167 mg, 0.75 mmol), 
(E)-ethyl 4-(4-chlorophenyl)-4-oxobut-2-enoate 44 (119 mg, 0.50 mmol), NHC precatalyst 2 
(9.2 mg, 25.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) were reacted for 4 h. The 
crude (80:20 dr) was purified by column chromatography (70:30 hexane : Et2O, minor-anti Rf 




+248.5 (c 0.27 in CHCl3); Chiral HPLC analysis, Chiralcel OD-H (95:5 hexane : IPA, flow 
rate 1 mLmin–1, 254 nm, 30 °C) tR (3R,4R): 14.3 min, tR (3S,4S): 15.7 min, >99:1 er; max (film, 
cm–1) 1765 (C=O), 1721 (C=O), 1657 (C=C); 1H NMR (300 MHz, CDCl3) H: 1.26 (3H, t, J 
7.2, OCH2CH3), 1.34 (3H, d, J 7.0, C(3)CH3), 2.92 (1H, pent, J 6.7, C(3)H), 3.44 (1H, t, J 6.3, 
C(4)H), 4.19 (2H, qd, J 7.1, 3.2, OCH2), 5.86 (1H, d, J 6.6, C(5)H), 7.35 (2H, d, J 8.7, 
ArC(2)H), 7.57 (2H, d, J 8.8, ArC(3)H); 13C{1H} NMR (75 MHz, CDCl3) C: 12.6 (C(3)CH3), 
14.2 (CH2CH3), 35.6 (C(3)H), 43.8 (C(4)H), 61.8 (OCH2), 98.4 (C(5)H), 126.3 (ArC), 128.9 
(ArCH), 130.5 (ArCH), 135.6 (ArC), 151.6 (C(6)), 169.6 (C(2)), 170.2 (CO2Et); HRMS (NSI
+) 
C15H16O4Cl [N+H]
+ found 295.0735, requires 295.0732 (+1.1 ppm). 
4.5.8 (3S,4S)-Ethyl 3-benzyl-2-oxo-6-(4-(trifluoromethyl)phenyl)-3,4-dihydro-2H-
pyran-4-carboxylate 27 
Following General Procedure 4.5, 1-oxo-3-phenylpropan-2-yl 4-nitrobenzoate 7 (224 mg, 
0.75 mmol), (E)-ethyl 4-oxo-4-(4-(trifluoromethyl)phenyl)but-2-enoate 45 (136 mg, 0.50 
mmol), NHC precatalyst 2 (18.3 mg, 50.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) 
were reacted for 3 h. The crude (80:20 dr) was purified by column chromatography (90:10 
petrol : EtOAc, major-syn Rf 0.16, minor-anti Rf 0.09) to give 27 (105 mg, 52%) as white solid. 
mp 145–147 °C (hexane); 20
D
][  +172.9 (c 0.31 in CHCl3); Chiral HPLC analysis, Chiralcel 
OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 ºC) tR (3S,4S): 18.8 min, tR (3R,4R): 
15.4 min, >99:1 er; max (film, cm–1) 1775 (C=O), 1719 (C=O), 1659 (C=C); 1H NMR (300 
MHz, CDCl3) H: 1.30 (3H, t, J 7.2, OCH2CH3), 2.78 (1H, dd, J 14.4, 9.9, C(3)HaHb), 2.98–
3.06 (1H, m, C(3)H), 3.30 (1H, t, J 6.4, C(4)H), 3.55 (1H, dd, J 14.2, 4.7, C(3)HaHb), 4.23 (2H, 
q, J 7.2, OCH2), 5.92 (1H, d, J 7.0, C(5)H), 7.17–7.19 (2H, m, C(3)CH2ArC(2)H), 7.24–7.36 
(3H, m, C(3)CH2ArC(3)H and C(3)CH2ArC(4)H), 7.63 (2H, d, J 8.5, C(6)ArC(2)H), 7.73 (2H, 
d, J 8.5, C(6)ArC(3)H); 13C{1H} NMR (75 MHz, CDCl3) C: 14.3 (CH3), 33.3 (CH2Ph), 40.8 
(C(3)H), 42.8 (C(4)H), 62.0 (OCH2), 100.3 (C(5)H), 124.0 (q, 
1JCF 272, CF3), 125.2 (ArCH), 
125.7 (q, 3JCF 3.8, C(6)ArC(3,5)H), 127.1 (ArCH), 129.0 (ArCH), 129.1 (ArCH), 131.4 (q, 
2JCF 
32.5, C(6)ArC(4)), 135.2 (ArC), 137.9 (ArC), 151.4 (C(6)), 168.4 (C(2)), 170.0 (CO2Et); 
HRMS (NSI+) C22H23O4NF3 [M+NH4]
+ found 422.1574, requires 422.1574 (+0.1 ppm).  
4.5.9 (3S,4S)-Ethyl 3-methyl-6-(naphthalen-2-yl)-2-oxo-3,4-dihydro-2H-pyran-4-
carboxylate 28 and (3S,4R)-Ethyl 3-methyl-6-(naphthalen-2-yl)-2-oxo-3,4-dihydro-2H-
pyran-4-carboxylate 29 
Following General Procedure 4.5, 1-oxopropan-2-yl 4-nitrobenzoate (167 mg, 0.75 mmol), 
(E)-ethyl 4-(naphthalen-2-yl)-4-oxobut-2-enoate 46 (127 mg, 0.50 mmol), NHC precatalyst 2 
(9.2 mg, 25.0 μmol), Et3N (105 μL, 0.75 mmol) and THF (5 mL) were reacted for 24 h. The 
crude (50:50 dr) was purified by column chromatography (90:10 petrol : EtOAc, anti Rf 0.29, 
syn Rf 0.23) to give syn-28 (49 mg, 32%) as white solid and anti-29 (55 mg, 35%) as white 
solid. syn-28: mp 101–103 °C (hexane); 20
D
][  +220.3 (c 0.34 in CHCl3); Chiral HPLC analysis, 
Chiralcel OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 °C) tR (3S,4S): 26.7 min, 
tR (3R,4R): 24.1 min, >99:1 er; max (film, cm–1) 1771 (C=O), 1715 (C=O), 1651 (C=C); 1H 
NMR (300 MHz, CDCl3) H: 1.27 (3H, t, J 7.2, OCH2CH3), 1.37 (3H, d, J 6.9, C(3)CH3), 2.97 
(1H, pent, J 6.7, C(3)H), 3.49 (1H, t, J 6.3, C(4)H), 4.15–4.26 (2H, m, OCH2), 6.02 (1H, d, J 
6.6, C(5)H), 7.48–7.53 (2H, m, ArH), 7.65 (1H, dd, J 8.7, 1.9, ArC(2)H), 7.78–7.91 (3H, m, 
ArH), 8.16–8.22 (1H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) C: 12.7 (C(3)CH3), 14.2 
(CH2CH3), 35.7 (C(3)H), 43.9 (C(4)H), 61.8 (OCH2), 98.5 (C(5)H), 122.1 (ArCH), 124.6 
(ArCH), 126.8 (ArCH), 127.1 (ArCH), 127.7 (ArCH), 128.4 (ArCH), 128.8 (ArCH), 129.0 
(ArC), 133.1 (ArC), 133.7 (ArC), 152.4 (C(6)), 170.0 (C(2)), 170.3 (CO2Et); HRMS (NSI
+) 
C19H19O4 [M+H]
+ found 311.1282, requires 311.1278 (+1.3 ppm). 
anti-29: mp 92–94 °C (hexane); 20
D
][  –91.9 (c 0.37 in CHCl3); Chiral HPLC analysis, 
Chiralcel OD-H (95:5 hexane : IPA, flow rate 1 mLmin–1, 254 nm, 30 °C) tR (3R,4S): 15.2 min, 
tR (3S,4R): 15.9 min, >99:1 er; max (film, cm–1) 1769 (C=O), 1728 (C=O), 1661 (C=C); 1H 
NMR (300 MHz, CDCl3) H: 1.33 (3H, t, J 7.2, OCH2CH3), 1.40 (3H, d, J 6.9, C(3)CH3), 3.10–
3.20 (1H, m, C(3)H), 3.38 (1H, dd, J 9.1, 4.0, C(4)H), 4.27 (2H, q, J 7.2, OCH2), 5.86 (1H, d, 
J 4.2, C(5)H), 7.48–7.53 (2H, m, ArH), 7.65 (1H, dd, J 8.7, 1.7, ArC(2)H), 7.79–7.93 (3H, m, 
ArH), 8.15–8.23 (1H, m, ArH); 13C{1H} NMR (75 MHz, CDCl3) C: 14.3 (CH2CH3), 15.0 
(C(3)CH3), 35.7 (C(3)H), 45.0 (C(4)H), 62.0 (OCH2), 98.0 (C(5)H), 122.0 (ArCH), 124.5 
(ArCH), 126.8 (ArCH), 127.0 (ArCH), 127.7 (ArCH), 128.4 (ArCH), 128.8 (ArCH), 128.8 
(ArC), 133.1 (ArC), 133.7 (ArC), 150.9 (C(6)), 170.3 (CO2Et), 171.5 (C(2)); HRMS (NSI
+) 
C19H19O4 [M+H]
+ found 311.1282, requires 311.1278 (+1.3 ppm). 
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